Cargando…

A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy

Although intraperitoneal chemotherapy (IPC) has evolved into an established treatment modality for patients with peritoneal metastasis (PM), drug penetration into tumor nodules remains limited. Drug transport during IPC is a complex process that depends on a large number of different parameters (e.g...

Descripción completa

Detalles Bibliográficos
Autores principales: Steuperaert, Margo, Debbaut, Charlotte, Carlier, Charlotte, De Wever, Olivier, Descamps, Benedicte, Vanhove, Christian, Ceelen, Wim, Segers, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450529/
https://www.ncbi.nlm.nih.gov/pubmed/30929523
http://dx.doi.org/10.1080/10717544.2019.1588423
_version_ 1783409039819931648
author Steuperaert, Margo
Debbaut, Charlotte
Carlier, Charlotte
De Wever, Olivier
Descamps, Benedicte
Vanhove, Christian
Ceelen, Wim
Segers, Patrick
author_facet Steuperaert, Margo
Debbaut, Charlotte
Carlier, Charlotte
De Wever, Olivier
Descamps, Benedicte
Vanhove, Christian
Ceelen, Wim
Segers, Patrick
author_sort Steuperaert, Margo
collection PubMed
description Although intraperitoneal chemotherapy (IPC) has evolved into an established treatment modality for patients with peritoneal metastasis (PM), drug penetration into tumor nodules remains limited. Drug transport during IPC is a complex process that depends on a large number of different parameters (e.g. drug, dose, tumor size, tumor pressure, tumor vascularization). Mathematical modeling allows for a better understanding of the processes that underlie drug transport and the relative importance of the parameters influencing it. In this work, we expanded our previously developed 3D Computational Fluid Dynamics (CFD) model of the drug mass transport in idealized tumor nodules during IP chemotherapy to include realistic tumor geometries and spatially varying vascular properties. DCE-MRI imaging made it possible to distinguish between tumorous tissues, healthy surrounding tissues and necrotic zones based on differences in the vascular properties. We found that the resulting interstitial pressure profiles within tumors were highly dependent on the irregular geometries and different zones. The tumor-specific cisplatin penetration depths ranged from 0.32 mm to 0.50 mm. In this work, we found that the positive relationship between tumor size and IFP does not longer hold in the presence of zones with different vascular properties, while we did observe a positive relationship between the percentage of viable tumor tissue and the maximal IFP. Our findings highlight the importance of incorporating both the irregular tumor geometries and different vascular zones in CFD models of IPC.
format Online
Article
Text
id pubmed-6450529
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-64505292019-04-15 A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy Steuperaert, Margo Debbaut, Charlotte Carlier, Charlotte De Wever, Olivier Descamps, Benedicte Vanhove, Christian Ceelen, Wim Segers, Patrick Drug Deliv Research Article Although intraperitoneal chemotherapy (IPC) has evolved into an established treatment modality for patients with peritoneal metastasis (PM), drug penetration into tumor nodules remains limited. Drug transport during IPC is a complex process that depends on a large number of different parameters (e.g. drug, dose, tumor size, tumor pressure, tumor vascularization). Mathematical modeling allows for a better understanding of the processes that underlie drug transport and the relative importance of the parameters influencing it. In this work, we expanded our previously developed 3D Computational Fluid Dynamics (CFD) model of the drug mass transport in idealized tumor nodules during IP chemotherapy to include realistic tumor geometries and spatially varying vascular properties. DCE-MRI imaging made it possible to distinguish between tumorous tissues, healthy surrounding tissues and necrotic zones based on differences in the vascular properties. We found that the resulting interstitial pressure profiles within tumors were highly dependent on the irregular geometries and different zones. The tumor-specific cisplatin penetration depths ranged from 0.32 mm to 0.50 mm. In this work, we found that the positive relationship between tumor size and IFP does not longer hold in the presence of zones with different vascular properties, while we did observe a positive relationship between the percentage of viable tumor tissue and the maximal IFP. Our findings highlight the importance of incorporating both the irregular tumor geometries and different vascular zones in CFD models of IPC. Taylor & Francis 2019-03-31 /pmc/articles/PMC6450529/ /pubmed/30929523 http://dx.doi.org/10.1080/10717544.2019.1588423 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Steuperaert, Margo
Debbaut, Charlotte
Carlier, Charlotte
De Wever, Olivier
Descamps, Benedicte
Vanhove, Christian
Ceelen, Wim
Segers, Patrick
A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title_full A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title_fullStr A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title_full_unstemmed A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title_short A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
title_sort 3d cfd model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450529/
https://www.ncbi.nlm.nih.gov/pubmed/30929523
http://dx.doi.org/10.1080/10717544.2019.1588423
work_keys_str_mv AT steuperaertmargo a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT debbautcharlotte a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT carliercharlotte a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT deweverolivier a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT descampsbenedicte a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT vanhovechristian a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT ceelenwim a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT segerspatrick a3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT steuperaertmargo 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT debbautcharlotte 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT carliercharlotte 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT deweverolivier 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT descampsbenedicte 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT vanhovechristian 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT ceelenwim 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy
AT segerspatrick 3dcfdmodeloftheinterstitialfluidpressureanddrugdistributioninheterogeneoustumornodulesduringintraperitonealchemotherapy